Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review. | NPJ Precis Oncol | 2025 | 40738965 | PubTator, text mining | PubMed |
| Editorial: Editor's feature: negative findings in pharmacogenetics and pharmacogenomics volume II. | Front Pharmacol | 2025 | 40735478 | PubTator, text mining | PubMed |
Association of the expression of 5-FU biomarkers with aging and prognosis in elderly patients with lung cancer treated with S-1 adjuvant chemotherapy: Follow-up results of the Setouchi Lung Cancer Group Study 1201. | Mol Clin Oncol | 2025 | 40692744 | PubTator, text mining | PubMed |
| Preventing adverse drug reactions and more: current clinical use of pharmacogenetic testing. | Med Genet | 2025 | 40687883 | PubTator, text mining | PubMed |
| Unrecognized mutations in DPYD* 2 A wild-type rectal cancer patients receiving postoperative 5-FU-based chemotherapy - do they have a clinical impact? | Cancer Chemother Pharmacol | 2025 | 40659880 | PubTator, text mining | PubMed |
| Establishing Best Practices for Clinical GWAS: Tackling Imputation and Data Quality Challenges. | Int J Mol Sci | 2025 | 40650174 | PubTator, text mining | PubMed |
| Utilisation of drugs with pharmacogenetic recommendations in children in Switzerland. | Pharmacogenomics J | 2025 | 40645942 | PubTator, text mining | PubMed |
| Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer. | Br J Pharmacol | 2025 | 40624839 | PubTator, text mining | PubMed |
| DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World Study. | Fundam Clin Pharmacol | 2025 | 40623917 | PubTator, text mining | PubMed |
| Genetic mechanism of β-alanine metabolic pathway affecting colorectal cancer prognosis. | BMC Gastroenterol | 2025 | 40597677 | PubTator, text mining | PubMed |
| Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes. | Clin Pharmacol Ther | 2025 | 40579854 | PubTator, text mining | PubMed |
| Identification of novel therapeutic targets for cognitive performance and associations with brain health. | Transl Psychiatry | 2025 | 40562807 | PubTator, text mining | PubMed |
| Exome Study of Single Nucleotide Variations in Patients with Syndromic and Non-Syndromic Autism Reveals Potential Candidate Genes for Diagnostics and Novel Single Nucleotide Variants. | Cells | 2025 | 40558542 | PubTator, text mining | PubMed |
| Oncology Specialists' Perceptions and Insights Into Dihydropyrimidine Dehydrogenase Testing in Palestine. | Cancer Rep (Hoboken) | 2025 | 40556331 | PubTator, text mining | PubMed |
| Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study. | Clin Pharmacol Ther | 2025 | 40552566 | PubTator, text mining | PubMed |
| Real-world study on fluoropyrimidine-related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype-guided dosing. | Int J Cancer | 2025 | 40536615 | PubTator, text mining | PubMed |
| Differential expression of capecitabine-related metabolic enzymes in hepatocellular carcinoma and its clinical value: a retrospective cohort study. | Discov Oncol | 2025 | 40504344 | PubTator, text mining | PubMed |
| Optimizing fluoropyrimidine therapy through dihydropyrimidine dehydrogenase polymorphism testing. | World J Gastrointest Oncol | 2025 | 40487937 | PubTator, text mining | PubMed |
| Human xenobiotic metabolism proteins have full-length and split homologs in the gut microbiome. | G3 (Bethesda) | 2025 | 40482059 | PubTator, text mining | PubMed |
| Precision Treatment of Patients With GI Cancer Using Pre-emptive DPYD Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-Fluorouracil. | JCO Precis Oncol | 2025 | 40479625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=8